Accelerated Biosciences Corp. is commercializing human trophoblast stem cells isolated from the trophectoderm of embryos from women with ectopic pregnancies. hTSCs are ethically sourced and have immune-privileged characteristics. It is an abundant and dynamic pluripotent stem cell platform for basic research, disease modeling, toxicology, drug discovery, and cell therapy.
Company Details
- Employees
- 12
- Founded
- 2013
- Address
- 3675 Market St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- acceleratedbiosciences.com
- Keywords
- King of Prussia.
- HQ
- Philadelphia, Pennsylvania
Accelerated Biosciences Corp. Questions
Accelerated Biosciences Corp.'s website is acceleratedbiosciences.com
Accelerated Biosciences Corp.'s LinkedIn profile is https://www.linkedin.com/company/accelerated-biosciences-corp.
Accelerated Biosciences Corp. has
12 employees.
View email and phone details for 12
employees at Accelerated Biosciences Corp..
Accelerated Biosciences Corp.'s industry is
Biotechnology Research
Accelerated Biosciences Corp.'s top competitors are
Verismo Therapeutics,
Agathos Biologics,
Tomorrow Biostasis Gmbh,
Passage Bio,
Xylocor Therapeutics, Inc.,
Aspen Neuroscience, Inc.,
Carisma Therapeutics,
Century Therapeutics, Inc,
Zmi Electronics Ltd.,
Stemmatters.
Accelerated Biosciences Corp.'s categories are Biotechnology Research
Accelerated Biosciences Corp.'s founding year is 2013
